Torion Technologies, Inc. Partners with Smiths Detection
Torion Technologies, Inc. (American Fork, Utah), a manufacturer of automated miniaturized, hand-portable GC and toroidal ion trap mass spectrometry (TMS) technology, has announced a partnership with Smiths Detection (Danbury,Connecticut), part of the global technology business, Smiths Group, and a technology developer and manufacturer of sensors that detect and identify explosives, chemical and biological agents, weapons, and contraband.
Torion Technologies, Inc. (American Fork, Utah), a manufacturer of automated miniaturized, hand-portable GC and toroidal ion trap mass spectrometry (TMS) technology, has announced a partnership with Smiths Detection (Danbury,Connecticut), part of the global technology business, Smiths Group, and a technology developer and manufacturer of sensors that detect and identify explosives, chemical and biological agents, weapons, and contraband.
According to the companies, the alliance enables the joint development of a next-generation, hand-portable GC–TMS system for the security, defense, and civil emergency responder markets. This technology is designed to identify a variety of substances such as chemical warfare agents (CWAs) and simulants, volatile and semivolatile organic compounds (VOCs and SVs), and other hazardous compounds.
Measuring Stress and Reproductive Hormones in Dolphins with UPLC
November 25th 2024A recent study measured stress and reproductive hormones in three stocks of free-ranging bottlenose dolphins inhabiting different natural salinities across the Gulf of Mexico, with hormones extracted from the blubber of 82 remotely biopsied dolphins and quantified using ultra performance liquid chromatography (UPLC) coupled with orbitrap fusion mass spectrometry.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
